Advancing Cancer Immunotherapy with InfinixBio

InfinixBio has collaborated with a biotechnology client to develop a groundbreaking delivery system targeting key cytokines directly to the tumor microenvironment, enhancing cancer treatment efficacy.

Client’s Goals:

The objective was to progress multiple therapeutics through detailed pre-clinical testing to obtain FDA approval and move into clinical trials.

Challenges Faced:

The client needed sophisticated expertise to test the safety and effectiveness of their therapeutics, requiring detailed analysis of complex biotherapeutic molecules and animal-derived samples.

Solutions Provided by InfinixBio:

Our team implemented a thorough approach:

Developed functional potency assays to verify therapeutic molecule activity.
Selected an appropriate animal model for pre-clinical testing.
Established qualified assays for bioanalysis and pharmacokinetic analysis.
Performed Anti Drug Antibody (ADA) analysis of animal study samples.
Prepared and documented results for FDA submission.

Results:

Our detailed and compliant efforts enabled the client to successfully initiate human clinical trials, marking a significant advancement in cancer therapy.